📣 VC round data is live. Check it out!
- Public Comps
- JETEMA Co.
JETEMA Co. Valuation Multiples
Discover revenue and EBITDA valuation multiples for JETEMA Co. and similar public comparables like Reckitt Benckiser, NN, AVITA Medical, Weight Watchers and more.
JETEMA Co. Overview
About JETEMA Co.
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.
Founded
2009
HQ

Employees
N/A
Website
Financials (FY)
EV
$208M
Valuation Multiples
Start free trialJETEMA Co. Financials
JETEMA Co. reported last fiscal year revenue of $51M and EBITDA of $8M.
In the same fiscal year, JETEMA Co. generated $24M in gross profit, $8M in EBITDA, and had net loss of ($4M).
Revenue (LTM)
JETEMA Co. P&L
In the most recent fiscal year, JETEMA Co. reported revenue of $51M and EBITDA of $8M.
JETEMA Co. is unprofitable as of last fiscal year, with gross margin of 48%, EBITDA margin of 15%, and net margin of (9%).
Financial data powered by Morningstar, Inc.
JETEMA Co. Stock Performance
JETEMA Co. has current market cap of $133M, and enterprise value of $208M.
Market Cap Evolution
JETEMA Co.'s stock price is $3.72.
JETEMA Co. share price decreased by 21.4% in the last 30 days, and by 20.9% in the last year.
JETEMA Co. has an EPS (earnings per share) of $-0.12.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $208M | $133M | 2.4% | -21.4% | -43.5% | -20.9% | $-0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJETEMA Co. Valuation Multiples
JETEMA Co. trades at 4.1x EV/Revenue multiple, and 27.3x EV/EBITDA.
EV / Revenue (LTM)
JETEMA Co. Financial Valuation Multiples
As of May 23, 2026, JETEMA Co. has market cap of $133M and EV of $208M.
JETEMA Co. has a P/E ratio of (30.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified JETEMA Co. Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


JETEMA Co. Margins & Growth Rates
In the most recent fiscal year, JETEMA Co. reported gross margin of 48%, EBITDA margin of 15%, and net margin of (9%).
JETEMA Co. Margins
JETEMA Co. Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
JETEMA Co. Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
JETEMA Co. Competitors
JETEMA Co. competitors include Reckitt Benckiser, NN, AVITA Medical, Weight Watchers, Cosmax BTI, CROSSJECT, Nyxoah, Paxman, Quanterix and Medifast.
Most JETEMA Co. public comparables operate across Health & Beauty, Medical Devices, BioTech, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.7x | — | 11.9x | — | |||
| 0.8x | 0.8x | 6.8x | 6.4x | |||
| 2.4x | 2.3x | (4.3x) | (5.1x) | |||
| 0.6x | 0.7x | (2.4x) | 3.5x | |||
| 0.9x | — | 7.7x | — | |||
| 13.9x | 6.1x | (22.7x) | 26.8x | |||
| 11.8x | 5.9x | (1.5x) | (1.6x) | |||
| 3.3x | 3.0x | 36.3x | 23.8x | |||
This data is available for Pro users. Sign up to see all JETEMA Co. competitors and their valuation data. Start Free Trial | ||||||
JETEMA Co. Investment Activity
JETEMA Co. has invested in 2 companies to date.
Latest investment by JETEMA Co. was on June 27th 2024. JETEMA Co. invested in Morpheus3d in their $2M Strategic investment round (EV/Revenue multiple of ).
Latest Investments by JETEMA Co.
| Description | Morpheus3d is a South Korea-based manufacturer of 3D-printed medical devices and surgical guides for orthopedic and dental procedures. Established in 2017 in Seoul, it produces patient-specific implants using titanium alloys and biocompatible resins for hospitals including Samsung Medical Center. Morpheus3d certifies products under KFDA standards with exports to Japan and Southeast Asia. | Feroka is a South Korea-based biotech company developing dissolvable microneedle patch technology for targeted drug delivery. The platform enables precise dosing to epidermis or dermis layers for vaccines, cosmetics, and therapeutics. Patches feature a melting shaft for painless application and easy removal. Headquartered in Seoul and founded in 2020, Feroka collaborates with pharmaceutical firms on clinical trials for dermatology and pain management applications. |
| HQ Country | ||
| HQ City | Suwon | Seoul |
| Deal Date | 27 Jun 2024 | 24 Aug 2022 |
| Round | Strategic investment | Series B |
| Raised | $2M | $8M |
| Investors | JETEMA Co. | HB Investment; IBK Capital; JETEMA Co.; Welcome Capital |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all JETEMA Co. investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout JETEMA Co.
| When was JETEMA Co. founded? | JETEMA Co. was founded in 2009. |
| Where is JETEMA Co. headquartered? | JETEMA Co. is headquartered in South Korea. |
| Is JETEMA Co. publicly listed? | Yes, JETEMA Co. is a public company listed on Korea Exchange. |
| What is the stock symbol of JETEMA Co.? | JETEMA Co. trades under 216080 ticker. |
| When did JETEMA Co. go public? | JETEMA Co. went public in 2019. |
| Who are competitors of JETEMA Co.? | JETEMA Co. main competitors include Reckitt Benckiser, NN, AVITA Medical, Weight Watchers, Cosmax BTI, CROSSJECT, Nyxoah, Paxman, Quanterix, Medifast. |
| What is the current market cap of JETEMA Co.? | JETEMA Co.'s current market cap is $133M. |
| What is the current revenue of JETEMA Co.? | JETEMA Co.'s last fiscal year revenue is $51M. |
| What is the current EV/Revenue multiple of JETEMA Co.? | Current revenue multiple of JETEMA Co. is 4.1x. |
| Is JETEMA Co. profitable? | No, JETEMA Co. is not profitable. |
| How many companies JETEMA Co. has acquired to date? | JETEMA Co. hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies JETEMA Co. has invested to date? | As of May 2026, JETEMA Co. has invested in 2 companies. |
| What was the last JETEMA Co. investment? | On 27th June 2024 JETEMA Co. invested in Morpheus3d, participating in a $2M Strategic investment round. |
| In what companies JETEMA Co. invested in? | JETEMA Co. invested in Feroka and Morpheus3d. |
See public comps similar to JETEMA Co.
Lists including JETEMA Co.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
